Inhibition of Histone Deacetylase 6 (HDAC6) Disrupts the Tolerogenic STAT3 Signaling Pathway and Augments Antitumor Immune Responses in Mantle Cell Lymphoma (MCL)

被引:0
|
作者
Wang, Hongwei [1 ]
Cheng, Fengdong [1 ]
Wang, Zi [1 ]
Lienlaf, Maritza [1 ]
Perez-Villarroel, Patricio [1 ]
Knox, Tessa [1 ]
Sahakian, Eva [1 ]
Pinilla-Ibarz, Javier [1 ]
Horna, Pedro [1 ]
Chen-Kiang, Selina [2 ]
Martin, Peter [2 ]
Bergman, Joel [3 ]
Kozikowski, Alan [3 ]
Villagra, Alejandro [1 ]
Tao, Jianguo [1 ]
Shah, Bijal D. [1 ]
Sotomayor, Eduardo M. [1 ]
机构
[1] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA
[2] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY USA
[3] Univ Illinois Chicago Coll Pharm, Chicago, IL USA
关键词
D O I
10.1182/blood.V120.21.3724.3724
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
3724
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Efficacy of a new small-molecule inhibitor of histone deacetylase 6 (HDAC6) in preclinical models of B-cell lymphoma and acute myeloid leukemia
    Villanueva, Lorea
    Perez-Salvia, Montserrat
    Aldaba, Eneko
    Vara, Yosu
    Fabre, Myriam
    Ferrer, Cristina
    Masdeu, Carme
    Zubia, Aizpea
    San Sebastian, Eider
    Otaegui, Dorleta
    Llinas-Arias, Pere
    Rossello-Tortella, Margalida
    Berdasco, Maria
    Setien, Fernando
    Moutinho, Catia
    Villanueva, Alberto
    Gonzalez-Barca, Eva
    Muncunill, Josep
    Tomas Navarro, Jose
    Angel Piris, Miguel
    Cossio, Fernando
    Esteller, Manel
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [22] Efficacy of a New Small-Molecule Inhibitor of Histone Deacetylase 6 (HDAC6) in Preclinical Models of B-Cell Lymphoma and Acute Myeloid Leukemia
    Perez-Salvia, Montserrat
    Eneko, Aldaba
    Yosu, Vara
    Myriam, Fabre
    Cristina, Ferrer
    Carme, Masdeu
    Aizpea, Zubia
    Sebastian Eider, San
    Dorleta, Otaegui
    Pere, Llinas-Arias
    Margalida, Rossello-Tortella
    Maria, Berdasco
    Fernando, Setien
    Catia, Moutinho
    Alberto, Villanueva
    Gonzalez-Barca, Eva
    Muncunill, Josep
    Tomas Navarro, Jose
    Angel Piris, Miguel
    Fernando, Cossio
    Esteller, Manel
    [J]. BLOOD, 2018, 132
  • [23] IL-6/STAT3 signaling pathway is activated in plasma cell mastitis
    Liu, Yang
    Zhang, Jian
    Zhou, Yu-Hui
    Jiang, Yi-Na
    Zhang, Wei
    Tang, Xiao-Jiang
    Ren, Yu
    Han, Shui-Ping
    Liu, Pei-Jun
    Xu, Jing
    He, Jian-Jun
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (10): : 12541 - 12548
  • [24] STAT3 Inhibition Unleashes TLR9-Induced B Cell Lymphoma Immunogenicity and T Cell-Dependent Antitumor Immune Responses
    Zhao, Xingli
    Zhang, Zhuoran
    Moreira, Dayson
    Swiderski, Piotr
    Kwak, Larry
    Forman, Stephen
    Kortylewski, Marcin
    [J]. MOLECULAR THERAPY, 2017, 25 (05) : 349 - 349
  • [25] Inhibition of STAT3 Reverses the Resistance to Histone Deacetylase Inhibitors Induced By Interleukin-6 in Chronic Lymphocytic Leukemia Cells
    Lu, Kang
    Wang, Xin
    Fang, Xiaosheng
    Feng, Lili
    Chen, Na
    Li, Peipei
    Li, Xinyu
    Geng, Lingyun
    [J]. BLOOD, 2014, 124 (21)
  • [26] Overexpression of HDAC6 suppresses tumor cell proliferation and metastasis by inhibition of the canonical Wnt/β-catenin signaling pathway in hepatocellular carcinoma
    Yin, Zhusheng
    Xu, Wei
    Xu, Hao
    Zheng, Junnian
    Gu, Yuming
    [J]. ONCOLOGY LETTERS, 2018, 16 (06) : 7082 - 7090
  • [27] Selective inhibition of HDAC6 sensitizes cutaneous T-cell lymphoma to PI3K inhibitors
    Bobrowicz, Malgorzata
    Slusarczyk, Aleksander
    Domagala, Joanna
    Dwojak, Michal
    Ignatova, Desislava
    Chang, Yun-Tsan
    Iselin, Christoph
    Miazek-Zapala, Nina
    Marhelava, Katsiaryna
    Guenova, Emmanuella
    Winiarska, Magdalena
    [J]. ONCOLOGY LETTERS, 2020, 20 (01) : 533 - 540
  • [28] Rapid Atrial Pacing Augments Fibrinogen Expression With Activation of IL-6/STAT3 Signaling Pathway in the Rat Liver
    Yaegashi, Takanori
    Kato, Takeshi
    Usui, Soichiro
    Kanamori, Naomi
    Furusho, Hiroshi
    Ootsuji, Hiroshi
    Takashima, Shinichiro
    Murai, Hisayoshi
    Kaneko, Shuichi
    Takamura, Masayuki
    [J]. CIRCULATION, 2014, 130
  • [29] Liraglutide activates nature killer cell-mediated antitumor responses by inhibiting IL-6/STAT3 signaling in hepatocellular carcinoma
    Lu, Xian
    Xu, Chun
    Dong, Jie
    Zuo, Shuguang
    Zhang, Hailin
    Jiang, Chunping
    Wu, Junhua
    Wei, Jiwu
    [J]. TRANSLATIONAL ONCOLOGY, 2021, 14 (01):
  • [30] Trilobolide-6-O-isobutyrate suppresses hepatocellular carcinoma tumorigenesis through inhibition of IL-6/STAT3 signaling pathway
    Zhou, Xiu-Qiao
    Mao, Xiao-Mei
    Fan, Rui
    Li, Si-Yang
    Shang, Jin
    Zhang, Tong
    Li, Rui-Han
    Li, Hui-Qi
    Hui, Yang
    Chen, Wen-Hao
    Wang, Zhan-Xiang
    Shen, Dong-Yan
    [J]. PHYTOTHERAPY RESEARCH, 2021, 35 (10) : 5741 - 5753